Mass General Hospital (MGH) — Boston, Massachusetts

Mass General Hospital (MGH) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass General Hospital (MGH) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter.

Sponsors: UroGen Pharma Ltd., Lantheus Medical Imaging.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Hospital (MGH)?

Mass General Hospital (MGH) has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Hospital (MGH) conducted?

Mass General Hospital (MGH) has 2 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter.

Is Mass General Hospital (MGH) accredited by Crixeo Health?

Mass General Hospital (MGH) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General Hospital (MGH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.